Atlas Trials

Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension

Clinical trial NCT02021292 · COMPLETED

Trial details

NCT number
NCT02021292
Sponsor
Actelion
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Thromboembolic Pulmonary Hypertension
Start date
2014-08-20
Primary completion
2016-09-28
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.